about
A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosisMycobacterium abscessus subsp. massiliense expressing bacterioferritin have improved resistance to stressful conditions
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-3329-7352
@en
name
Danilo Pires Resende
@ast
Danilo Pires Resende
@en
Danilo Pires Resende
@es
Danilo Pires Resende
@nl
type
label
Danilo Pires Resende
@ast
Danilo Pires Resende
@en
Danilo Pires Resende
@es
Danilo Pires Resende
@nl
prefLabel
Danilo Pires Resende
@ast
Danilo Pires Resende
@en
Danilo Pires Resende
@es
Danilo Pires Resende
@nl
P106
P21
P31
P496
0000-0002-3329-7352